124 related articles for article (PubMed ID: 35354463)
41. Implementing recommendations for the early detection of breast and cervical cancer among low-income women.
Lawson HW; Henson R; Bobo JK; Kaeser MK
MMWR Recomm Rep; 2000 Mar; 49(RR-2):37-55. PubMed ID: 15580731
[TBL] [Abstract][Full Text] [Related]
42. Evaluation of cervical cancer screening program at a rural community of South Africa.
Hoque M; Hoque E; Kader SB
East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
[TBL] [Abstract][Full Text] [Related]
43. Frequency of cervical cancer and breast cancer screening in HIV-infected women in a county-based HIV clinic in the Western United States.
Rahangdale L; Sarnquist C; Yavari A; Blumenthal P; Israelski D
J Womens Health (Larchmt); 2010 Apr; 19(4):709-12. PubMed ID: 20201703
[TBL] [Abstract][Full Text] [Related]
44. Increasing age predicts poor cervical cancer prognosis with subsequent effect on treatment and overall survival.
Quinn BA; Deng X; Colton A; Bandyopadhyay D; Carter JS; Fields EC
Brachytherapy; 2019; 18(1):29-37. PubMed ID: 30361045
[TBL] [Abstract][Full Text] [Related]
45. Characteristics of patients diagnosed with cervical cancer in Brazil: preliminary results of the prospective cohort EVITA study (EVA001/LACOG 0215).
Rodrigues AN; de Melo AC; Calabrich AFC; Cronenberger E; Torres KL; Damian F; Cossetti R; de Azevedo CRAS; da Fonseca AJ; Nerón Y; Nunes J; Lopes A; Thomé F; Leal R; Borges G; da Silva AF; Rodrigues MF; Nunes Filho PRS; Zaffaroni F; Freitas RDS; Werutsky G; Maluf F
Int J Gynecol Cancer; 2022 Feb; 32(2):141-146. PubMed ID: 34969827
[TBL] [Abstract][Full Text] [Related]
46. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
[TBL] [Abstract][Full Text] [Related]
47. Cytological screening history of patients with early invasive cervical cancer.
Turner MJ; Keane DP; Flannelly GM; Lenehan PM; Murphy JF; Foley ME
Ir Med J; 1990 Jun; 83(2):61-2. PubMed ID: 2202697
[TBL] [Abstract][Full Text] [Related]
48. Cost-effectiveness of the conventional papanicolaou test with a new adjunct to cytological screening for squamous cell carcinoma of the uterine cervix and its precursors.
Taylor LA; Sorensen SV; Ray NF; Halpern MT; Harper DM
Arch Fam Med; 2000 Aug; 9(8):713-21. PubMed ID: 10927709
[TBL] [Abstract][Full Text] [Related]
49. Implementing the national invasive cervical cancer audit: a local perspective.
Moss EL; Pearmain P; Askew S; Owen G; Reynolds TM; Prabakar IM; Douce G; Parkes J; Menon V; Todd RW; Redman CW
BJOG; 2010 Oct; 117(11):1411-6. PubMed ID: 20716252
[TBL] [Abstract][Full Text] [Related]
50. Risk of invasive cervical cancer after three consecutive negative Pap smears.
Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
J Med Screen; 2003; 10(4):196-200. PubMed ID: 14738657
[TBL] [Abstract][Full Text] [Related]
51. [Studies on the appropriate frequency of the cervical cancer screening (author's transl)].
Hando T; Kodama S; Obata N; Goto A; Takeuchi S; Aoki S
Nihon Sanka Fujinka Gakkai Zasshi; 1981 Aug; 33(8):1205-8. PubMed ID: 7276648
[TBL] [Abstract][Full Text] [Related]
52. [Relation of cervical cancer with the results of human papillomavirus (HPV) screening carried out via hybrid capture 2 method on 52.000 women in Erzurum].
Göktuğ Kadıoğlu B; Çınar Tanrıverdi E; Alay H; Uçar M
Mikrobiyol Bul; 2018 Oct; 52(4):367-375. PubMed ID: 30522422
[TBL] [Abstract][Full Text] [Related]
53. [Organized cervical cancer screening for underpriviledged women].
Piana L; Leandri FX; Jacqueme B; Heid P; Corti J; Andrac-Meyer L; Sancho-Garnier H
Bull Cancer; 2007 May; 94(5):461-7. PubMed ID: 17535784
[TBL] [Abstract][Full Text] [Related]
54. [Women's social conditions and their participation in Cervical Cancer Population Screening Program in Poland].
Spaczyński M; Nowak-Markwitz E; Januszek-Michalecka L; Karowicz-Bilińska A
Ginekol Pol; 2009 Nov; 80(11):833-8. PubMed ID: 20088397
[TBL] [Abstract][Full Text] [Related]
55. Pap smear screening, pap smear abnormalities and psychosocial risk factors among women in a residential alcohol and drug rehabilitation facility.
Soccio J; Brown M; Comino E; Friesen E
J Adv Nurs; 2015 Dec; 71(12):2858-66. PubMed ID: 26279461
[TBL] [Abstract][Full Text] [Related]
56. Papanicolaou smear history of patients developing cervical cancer: an assessment of screening protocols.
Bearman DM; MacMillan JP; Creasman WT
Obstet Gynecol; 1987 Feb; 69(2):151-5. PubMed ID: 3808501
[TBL] [Abstract][Full Text] [Related]
57. About invasive cervical cancer: a French population based study between 1998 and 2010.
Lorin L; Bertaut A; Hudry D; Beltjens F; Roignot P; Bone-Lepinoy MC; Douvier S; Arveux P
Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():1-6. PubMed ID: 26004674
[TBL] [Abstract][Full Text] [Related]
58. Cervix cancer screening in Croatia within the European Cervical Cancer Prevention Week.
Skopljanac-Macina L; Mahovlić V; Ovanin-Rakić A; Barisić A; Rajhvajn S; Juric D; Babić D; Corusić A; Oresković S
Coll Antropol; 2010 Jun; 34(2):613-7. PubMed ID: 20698138
[TBL] [Abstract][Full Text] [Related]
59. Prevalence of cervical abnormalities among rural women in KwaZulu-Natal, South Africa.
Omoyeni OM; Tsoka-Gwegweni JM
Pan Afr Med J; 2022; 41():110. PubMed ID: 35432696
[TBL] [Abstract][Full Text] [Related]
60. Cancer diagnosis after a report of negative cervical cytology.
Mitchell HS; Giles GG
Med J Aust; 1996 Mar; 164(5):270-3. PubMed ID: 8628160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
